7
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The Human Insulin Receptor Cdna: A New Tool to study the Function of this Receptor

, , , , &
Pages 377-404 | Published online: 26 Sep 2008
 

Abstract

The human insulin receptor (hIR) is an integral transmembrane glycoprotein comprised of two α and two β subunits. An immediate consequence of insulin binding to the extracellular α subunit is the autophosphorylation of tyrosine residues on the intracellular domain of the β subunit. The placental hIR cDNA has been cloned and sequenced, providing the primary structural features of the protein.

In order to investigate the functions of the β subunit and particularly the role of autophosphorylation and tyrosine phosphokinase (TPK) activity (a feature shared by other receptors and oncogene proteins) in transmembrane signalling, we designed an expression system of the hIR cDNA in eucaryotic cells. Superexpressing CHO cell lines that contain about 106 functional hIR/cell have been developed. In these cells half maximum stimulation of glucose uptake occurs at 5x 10-10M insulin, whereas normal CHO cells require 5x 10-12M insulin. In this expression system we have carried out site-directed mutagenesis experiments in which domains of the molecule have been deleted or particular amino acids have been replaced by others. The replacement of either or both the tyrosine residues 1162 and 1163 compromise an autophosphorylated site that is important for kinase function and the insulin response. Expression of an isolated membrane-bound form of the β-subunit produces a 6 fold increase in glucose uptake. This insulin-independent effect disappears if the twin tyrosines are mutated or if the β subunit is expressed in the cytoplasm. These studies also show that the C terminal 112 amino acid portion of the β subunit is important for the stability of this protein.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.